COMP <GO>
G vs PG // 10Y YIELD & FRED MACRO BETA
Genpact Limited (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: G 6
— PG 8
▲ 10Y YIELD & FRED MACRO BETA LEADER: G
LAST: $39.62 (+1.67%) • MKT CAP: $6.52B
macro-sensitivity
0.89
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
macro-sensitivity
0.87
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (G VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | G | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.00% | 51.20% | -15.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.70% | 25.40% | -4.70 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 8.4x | 16.2x | -7.80 | G | /valuation <GO> |
| Free Cash Flow Yield | 11.27% | 3.77% | +7.50 | G | /fcf-yield <GO> |
| Operating Margin | 14.80% | 24.30% | -9.50 | PG | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 19.00% | -8.10 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 6.60% | 0.30% | +6.30 | G | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.81% | 2.65% | -0.84 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.03 | 5.59 | -2.56 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | G | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.50% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.5 | 62.7 | -0.13 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.89 | 0.87 | +0.02 | G | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.0x | 21.7x | -10.70 | G | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.52B | $372.21B | -$365.70B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | G REV | PG REV | G GROSS % | PG GROSS % | G FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.08B | $84.28B | 36.0% | 51.2% | $734.7M | $14.04B |
| FY 2024 | $4.77B | $84.04B | 35.5% | 51.4% | $532.7M | $16.52B |
| FY 2023 | $4.48B | $82.01B | 44.0% | 44.0% | $289.4M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
G // BETA 0.89
PG // BETA 0.87